Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Trimegah Karya Pratama Tbk. (UVCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Trimegah Karya Pratama Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Trimegah Karya Pratama Tbk. trades at Rp145 (market cap 292.02B, 23.12M 24h volume). The key difference: Trimegah Karya Pratama Tbk. is the larger of the two by market cap, and Trimegah Karya Pratama Tbk. is more actively traded (23.12M versus 62.5K). Which is the better fit depends on your goals.
| OBAT | UVCR | |
|---|---|---|
Market Cap | 164.65B | 292.02B |
Volume | 62.5K | 23.12M |
Lot | 625 | 231.22K |
Turnover | 15.03M | 3.33B |
Average Price | 240.55 | 144.04 |
Value | 15.03M | 3.33B |
Indicative Equilibrium Price | 238 | 145 |
Indicative Equilibrium Volume | 100 | 1.76K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Trimegah Karya Pratama Tbk.
PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Read more on UVCR →
